Introduction
The vertebrate retina consists of six major classes of neurons and one class of glial cells, which are organized into distinct layers (Dowling, 1987) . In the vertebrate retina, neuroepithelial cells are initially mitotic and undergo cell division to generate two mitotic daughter cells. At the stage when neuronal differentiation occurs, progenitor cells start cell division, producing postmitotic progenies, which exit from the cell cycle and differentiate into retinal neurons or glial cells. Cell fate decisions in the developing retina are independent of cell lineage; therefore it seems likely that multipotent progenitor cells change their competence to generate different retinal cell types in response to position and stage-dependent environmental cues (Livesey and Cepko, 2001; Marquardt and Gruss, 2002) . Although the generation of postmitotic neuronal progenies, referred to as 'neuronal production' in this paper, is the first step of neuronal differentiation, it is still unclear how mitotic retinoblasts determine when they generate postmitotic progenies.
In all cell types, progression of the cell cycle is regulated by different combinations of cyclins and cyclin-dependent kinases (cdks) (Murray, 2004) . Cyclin D1 is expressed abundantly in the developing retina and is important for progression of the cell cycle in vertebrates (Sicinski et al., 1995; Fantl et al., 1995) , including in zebrafish (Yarden et al., 1995) . Three major types of cdk inhibitor, Cip/Waf, Kip and INK4 family proteins, are important regulators of exit from the cell cycle (Galderisi et al., 2003) . Among these, a Kip family protein, p27, is expressed in the developing retina and plays a role in the exit of retinal progenitor cells from the cell cycle by the inhibition of cyclin D1 (Dyer and Cepko, 2001; Geng et al., 2001) . Several cell-extrinsic and -intrinsic factors regulating the cell cycle have been identified (Ohnuma and Harris, 2003; Levine and Green, 2004; Yang, 2004) . Wnt and Notch (N) are cellextrinsic regulators of the cell cycle that function upstream of cyclin D and p27 (van Es et al., 2003; Radtke and Raj, 2003) . In the chick retina, a Wnt family protein, Wnt2b, is expressed in mitotic progenitor cells and promotes cell proliferation (Kubo et al., 2003) . There were reports that cyclin D1 is a target of β-catenin/LEF-1, components of canonical Wnt signalling of Wnt signalling promotes proliferation even in the absence of PKA activity. These observations suggest that PKA inhibits exit from the Wnt-mediated cell cycle rather than stimulates Wnt-mediated cell-cycle progression. PKA is an inhibitor of Hh signalling, and Hh signalling molecule morphants show severe defects in cell-cycle exit of retinoblasts. Together, these data suggest that Hh acts as a short-range signal to induce the cell-cycle exit of retinoblasts. The pulse inhibition of Hh signalling revealed that Hh signalling regulates at least two distinct steps of RGC differentiation: the cell-cycle exit of retinoblasts and RGC maturation. This dual requirement of Hh signalling in RGC differentiation implies that the regulation of a neurogenic wave is more complex in the zebrafish retina than in the Drosophila eye. (Tetsu and McCormick, 1999; Shtutman et al., 1999) . N signalling promotes the exit of retinal progenitor cells from the cell cycle in Xenopus retinas (Ohnuma et al., 2002) , although N plays a role in the maintenance of neural stem cells in the brain (Radtke and Raj, 2003) . Although these factors have been identified, mechanisms underlying the exit of retinal progenitor cells from the cell cycle still remain to be elucidated. In zebrafish, postmitotic cells are initially generated in the ventronasal retina adjacent to the optic stalk, and neuronal production progresses to the entire neural retina (Hu and Easter, 1999) . Our previous study revealed that neuronal production is initiated by the interaction between the optic stalk and the neural retina, and that its progression to the entire neural retina is regulated by the relay of short-range signalling (Masai et al., 2000) . The progression of differentiation of retinal ganglion cells (RGCs) and photoreceptors in the zebrafish retina requires the signalling molecule Hedgehog (Hh) (Neumann and Nuesslein-Volhard, 2000; Stenkamp et al., 2000) (reviewed by Russell, 2003; Pujic and Malicki, 2004) . These observations raise the possibility that Hh signalling is a candidate for the short-range signalling required for neuronal production. However, the most recent study demonstrated that the expression of ath5, one of earliest markers of neuronal production, is suppressed in only 20% of embryos treated with the Hh inhibitor cyclopamine (Stenkamp and Frey, 2003) . Furthermore, the suppression of ath5 expression occurs only following treatment with cyclopamine before invagination of the optic cup, and the progression of ath5 expression is slightly delayed by the treatment with cyclopamine from the stage when Hh is expressed in the retina. Thus, Stenkamp and Frey predicted that both the initial induction and early progression of ath5 expression may be regulated by long-range Hhdependent midline signalling, and that short-range Hh signalling within the neural retina plays only a supplemental role in the progression of ath5 expression (Stenkamp and Frey, 2003) . Thus, it is still unclear whether Hh signalling essentially regulates the progression of ath5 expression and neuronal production.
Much of our knowledge about the mechanisms underlying the Hh signalling pathway is based on its genetic studies in Drosophila (reviewed by Ingham and McMahon, 2001; Cohen, 2003) . Hh is released from secreting cells and binds to the receptor protein Patched (Ptc) in responding cells, thereby relieving the Ptc-mediated inhibition of Smoothened (Smo), a seven transmembrane protein essential for the transduction of all Hh-signalling activity. Activated Smo signals to the transcription factor Cubitus interruptus (Ci), which acts as a bipotential transcription factor that can repress, as well as activate, Hh target genes. In the absence of Hh signalling, the repressor form is generated by proteolytic cleavage of fulllength protein, which is promoted by cAMP-dependent protein kinase (PKA)-mediated phosphorylation. In the presence of Hh signalling, the cleavage of Ci is inhibited and a full-length activator isoform predominates. It is the balance between these activator and repressor forms of Ci that determines the specific target genes that the cell expresses in response to a particular level of Hh-signalling activity. In vertebrates, at least three Ci homologous genes called Gli, Gli1, Gli2 and Gli3, mediate the transcriptional response to Hh signals. Less is known about Gli family functions than is known about Ci function. Gli1 does not undergo preteolytic cleavage and appears to be solely an activator of the Hh response. Gli2 and possibly Gli3 have both activator and repressor forms, although the in vivo cleavage of these proteins has not been directly demonstrated. In vertebrates, the activity of the Gli transcription factors is negatively regulated by PKA (Hammerschmidt et al., 1996) , which possibly acts to promote the cytoplasmic sequestration of Gli1 and generate the repressor forms of Gli2 and Gli3.
Here we show that forskolin treatment effectively inhibits the progression of neuronal production in the zebrafish retina. In the presence of forskolin, a few postmitotic cells are generated adjacent to the optic stalk, but neuronal production is completely inhibited in the remaining region of the neural retina. Forskolin activates adenynyl cyclase, which increases the level of cAMP and then the activity of PKA. The introduction of a dominant-negative form of PKA (dnPKA) rescues the progression of neuronal production in the presence of forskolin. These data clearly show that the initial induction of neurogenesis in the ventronasal retina is PKA-independent, and that the activation of PKA strongly inhibits the progression of retinal neurogenesis. In the presence of forskolin, almost all retinal cells fail to exit from the cell cycle but instead continue to proliferate, suggesting that PKA inhibits the cell-cycle exit of retinal progenitor cells. The introduction of a cdk inhibitor, p27, inhibits cell-cycle progression even in the presence of forskolin, suggesting that PKA functions upstream of p27. Blockade of Wnt signalling also inhibits cell-cycle progression in forskolin-treated retinas. However, the activation of Wnt signalling promotes the cell-cycle progression even in the absence of PKA activity. These observations suggest that Wnt activation is sufficient to maintain proliferation regardless of the level of PKA activity, and that PKA seems to inhibit exit from the Wnt-mediated cell cycle rather than stimulate Wntmediated cell-cycle progression. Cell-cycle exit of retinoblasts is similarly affected by blockade of the Hh signalling pathway. Together, these data suggest that Hh signalling regulates the progression of neuronal production.
In Drosophila, Hh is activated in differentiating photoreceptors and acts on adjacent uncommitted cells causing them to differentiate into photoreceptors, which in turn become a new source of Hh signals (Kumar, 2001) . Zebrafish sonic hh (shh) and tiggy-winkle hh (twhh) are expressed in RGCs and induce RGC differentiation non-cell-autonomously (Neumann and Nuesslein-Volhard, 2000) , raising the possibility that Hh emanating from RGCs induces neighbouring progenitor cells to generate postmitotic cells, which in turn become a source of Hh signals. However, pulse treatment with forskolin shows that Hh regulates at least two distinct steps of RGC differentiation: cell-cycle exit of retinoblasts and progression of postmitotic cells into mature RGCs. This dual requirement of Hh signalling implies that the mechanism underlying a neurogenic wave in the zebrafish retina is more complex than that in the Drosophila eye.
Materials and methods

Fish
Zebrafish (Danio rerio) were maintained at 28.5°C on a 14-hour light/10-hour dark cycle. Embryos were collected by natural spawning. The smu b577 alleles were used (Varga et al., 2001) . Two transgenic strains carrying the green fluorescent protein (GFP) under the control of ath5 (Masai et al., 2003) and shh retinal enhancers (Neumann and Nuesslein-Volhard, 2000) were used; they are referred to as Tg(ath5:GFP) and Tg(shh:GFP), respectively, in this paper. The TOPdGFP transgenic line (Dorsky et al., 2002) carries GFP under the control of a β-catenin-responsive promoter and was used to monitor the activation of canonical Wnt signalling.
The treatment with forskolin and cyclopamine Embryos were treated with forskolin according to the procedure previously described (Barresi et al., 2000) . As Hh-dependent midline signalling promotes the fate of the optic stalk and represses that of the neural retina (Macdonald et al., 1995) , forskolin treatment from early stages causes the cyclopia phenotype (Barresi et al., 2000) . To prevent this defect, forskolin was applied to embryos after the regional specification of the optic cup, by midline signalling, is completed. All treatments with forskolin in this study were carried out from 18 hours postfertilisation (hpf), except the pulse treatment shown in Fig. 6 . According to the previous study (Neumann and Nuesslein-Volhard, 2000) , cyclopamine (TRC Biomedical Research Chemicals, New York, Ontario, Canada) was dissolved in ethanol and diluted to a final concentration of 100 µM for use. We also used cyclopamine-KAAD (Calbiochem) at a final concentration of 75 µM.
In situ hybridisation, antibody labelling, plastic sectioning and cell transplantation Whole-mount in situ hybridisation, antibody labelling, plastic sectioning and cell transplantation were performed as described previously (Masai et al., 2003) . Antibody labelling was carried out using an anti-phosphorylated histone H3 antibody (Upstate Biotechnology) at 1:500, an anti-tubulin antibody (Sigma) at 1:1000, an anti-myc antibody (CALBIOCEM) at 1:200, an antibromodeoxyuridine (BrdU) antibody (Roche) at 1:100, an anti-CREB antibody (Cell signaling) at 1:1000, an anti-phosphorylated CREB antibody (Ser133) (Cell signaling) at 1:1000, and an Alexa-532-conjugated anti-mouse or anti-rabbit IgG antibody (Molecular Probes) at 1:500.
BrdU incorporation
Dechorionated embryos were soaked for 30 minutes in Ringer's solution containing 10 mM BrdU (Sigma) and 15% dimethyl sulfoxide (DMSO) at 6°C. After BrdU treatment, the embryos were washed, incubated for 30 minutes in Ringer's solution at 28.5°C and fixed with 4% paraformaldehyde (PFA). When embryos were older than 2 days postfertilization (dpf), Ringer's solution with 10 mM BrdU was injected into the yolk of embryos. After at least a 2-hour incubation at 28.5°C, the embryos were fixed with 4% PFA.
Labelling for apoptosis
Embryos were fixed with 4% PFA and sectioned at 8 µm on a microtome cryostat, HM550M-OM (MICROM International GmbH). Apoptotic cells were detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling (TUNEL) using an in situ cell death detection kit (Roche).
DNA constructs for expressing dnPKA, p27, ∆N-Tcf3 and ∆47-β-catenin The pCS2 vector (Rupp et al., 1994 ) carrying mouse dnPKA was described by Ungar and Moon (Ungar and Moon, 1996) . This plasmid was modified to generate the expression construct pCS2 [hsp:dnPKA] , by replacing the CMV promoter with a zebrafish heat-shock inducible promoter (hsp) (Halloran et al., 2000) . The coding region of Xenopus p27 (Su et al., 1995) and zebrafish ∆N-Tcf3 (Kim et al., 2000) was inserted into the pCS2MT expression vector, resulting in the addition of the myc-tag to the N terminus of these proteins. GFP was fused to the C terminus of the coding region of ∆47-β-catenin (Chenn and Walsh, 2002 were incubated at 39°C from 17 to 18 hpf, and soaked in water containing forskolin from 18 hpf. Embryos expressing dnPKA were fixed with 4% PFA at 33 hpf and examined for in situ hybridisation with the ath5 RNA probe. At 33 hpf, embryos expressing p27 or ∆Tcf3 were labelled with BrdU and then fixed with PFA at least 2 hours after the BrdU incorporation. These embryos were labelled with the anti-myc antibody and signals were visualised by staining with HRP-conjugated anti-mouse IgG antibodies (Histofine kit, Nichirei), using 3,3′-diaminobenzidine (DAB) (Sigma) as a substrate. These labelled embryos were sectioned using a cryostat and the cryosections were treated with 2N HCl for 60 minutes to expose the nuclei. After HCl treatment, sections were labelled with the anti-BrdU antibody and BrdU-positive areas were visualised as fluorescence by labelling with Alexa532-conjugated anti-mouse IgG antibody. HCl treatment seems to inactivate the epitope structures of the anti-myc antibody, resulting in an absence of cross-reactions between the Alexa532 anti-mouse IgG antibody and anti-myc antibody.
Co-expression of dnPKA and ∆47-β-catenin A mixture of plasmids, pCS2[hsp:dnPKA] (30 µg/ml) and pCS2[hsp:∆47-β-catenin-GFP] (30 µg/ml), was injected into embryos. Embryos were incubated at 39°C from 17 to 18 hpf, developed until 48 hpf and then fixed with 4% PFA.
Cloning of zebrafish homologues of the cdk inhibitor p27
We searched the zebrafish genomic database, which has been provided by the Wellcome Trust Sanger Institute, and identified two zebrafish homologues of p27. Their Ensembl gene identification numbers in this database are ENSDARG00000020832 and ENSDARG00000010878, which are referred to as p27a and p27b, respectively, hereafter. The sequences of p27a and p27b have been deposited in GenBank with the Accession numbers AF398516 and BI887574 (EST sequence), respectively. Their cDNA fragments were amplified by PCR using primers specific to their 5′ and 3′ sequences. The phylogenetic tree was constructed on the basis of the full-length amino acid sequences using the GENETYX-MAC program based on the Neighbour-Joining (NJ) method (Software Development).
Calculation of the ratio of BrdU-positive area to total area within the neural retina Cryosections labelled with the anti-BrdU antibody were scanned under a LSM 510 laser-scanning microscope (Carl Zeiss). Using NIH Image, BrdU signals were converted to a binary scale with two digits, 0 (negative) and 1 (positive), by which the BrdU-positive area is adjusted to the outlines of BrdU-positive cells. This procedure approximates the ratio of the BrdU-positive area to the total area to the ratio of BrdU-positive cell number to total cell number. The number of pixels corresponding to 1 and 0 within the neural retina was determined. The ratio of the BrdU-positive area to the total area was calculated as the ratio of the number of 1 pixels to the number of 1+0 pixels.
Morpholino oligonucleotide injection
Morpholinos were purchased from Gene Tools. Anti-sense morpholino oligonucleotides for shh (shh-MO), twhh (twhh-MO), Gli1 (Gli1-MO) and Gli2 (Gli2-MO) genes were designed as previously described (Nasevicius and Ekker, 2000; Karlstrom et al., 2003) . A mixture of shh-MO (1 mg/ml) and twhh-MO (1 mg/ml), or a mixture of Gli1-MO (1 mg/ml) and Gli2-MO (1 mg/ml), was injected into the yolk. Injected embryos were incubated until they reached the appropriate stage and then fixed with 4% PFA for in situ hybridisation, plastic section or antibody labelling.
Assessment of severity of the progression of ath5 expression in the blockade of Hh signalling
According to the severity of the defect in ath5 expression, embryos labelled with ath5 RNA probe were classified into four groups: no expression, severe, mild and normal. Severe means that ath5 expression is initiated in the ventronasal retina but fails to spread to the dorsal and temporal retina. Mild means that the progression of ath5 expression occurs to some degree but does not reach the whole of the neural retina. Typical examples are shown in Fig. 4L -L′′.
Results
Forskolin treatment effectively blocks the progression of ath5 expression and RGC differentiation Our previous study showed that a zebrafish homologue of Drosophila atonal, ath5, is expressed transiently in retinoblasts undergoing the final mitosis and also in their postmitotic daughter cells (Masai et al., 2000) (Fig. 5D ), indicating that ath5 is the earliest marker of neuronal production. In zebrafish, ath5 mRNA was expressed at the ventronasal retina at 25 hpf ( Fig. 1A) , and its expression spread to the dorsal and temporal regions in a fan-shaped manner at 27 hpf (Fig. 1B) . This fanshaped expression pattern spread from the central to peripheral regions in the later stages of development (31 hpf; Fig. 1C ).
The profile of ath5 expression agrees with that of neuronal production shown by a previous study using BrdU incorporation (Hu and Easter, 1999) . Another study demonstrated that the progression of ath5 expression is inhibited in only 20% of embryos treated with the Hh inhibitor cyclopamine (Stenkamp and Frey, 2003) , which is a teratogenic Veratrum alkaloid that inhibits the function of Smo (Cooper et al., 1998; Chen et al., 2002) . Here, we used another chemical, forskolin, which directly stimulates adenylyl cyclase to increase cellular cAMP levels, constitutively activating PKA, which inhibits Hh signalling (Barresi et al., 2000; Ingham and McMahon, 2001; Cohen, 2003) . Forskolin treatment did not affect the initiation of ath5 expression in a few cells adjacent to the optic stalk, but it completely blocked the progression of ath5 expression at 33 hpf (Fig. 1E ). The penetrance of this phenotype induced by forskolin treatment was almost 100% (n>100 embryos). The introduction of a dominant-negative PKA (dnPKA) rescued the progression of ath5 expression in forskolin-treated embryos ( Fig. 1F) , suggesting that the constitutive activation of PKA inhibits the progression of ath5 expression. Together, these data suggest that the initial induction of ath5 expression in the ventronasal retina is independent of PKA activity, and that a high level of PKA activity strongly inhibits the progression of ath5 expression to the rest of the neural retina. We confirmed that treatment with cyclopamine caused only a mild delay of ath5 expression (Fig. 1G,H) , indicating that the effect of forskolin on ath5 expression is more severe than that of cyclopamine.
As the removal of Ath5 function affects RGC differentiation (Kay et al., 2001) , we examined whether forskolin treatment affects the differentiation of RGCs. In forskolin-treated retinas, the differentiation makers of RGCs islet1 (Inoue et al., 1994) and lim3 (Glasgow et al., 1997) were normally expressed in a few cells adjacent to the optic stalk, but the progression of their expression was completely blocked (100%, n=20, Fig. 1J ; 100%, n=20, Fig. 1L ). These data indicate that the progression of RGC differentiation is blocked Development 132 (7) Research article by the forskolin treatment. As islet1/lim3-positive RGCs are considered to be derived from ath5-positive cells treated with forskolin, forskolin does not simply inhibit neuronal differentiation but seems to block a process required for the progression of neuronal differentiation. We also examined the differentiation of other retinal cell-types such as photoreceptors in forskolin-treated retinas. However, treatment with forskolin or DMSO induced massive cell death after 48 hpf, which masked any phenotype of their differentiation (data not shown; see Fig. 2J ). Thus, in this study, we focus upon the differentiation from retinoblasts to RGCs.
Forskolin treatment blocks cell-cycle exit of retinal progenitor cells
To examine whether forskolin-treated retinal cells are mitotic, we examined the markers of mitotic cells and BrdU incorporation. In 2-dpf wild-type retinas, rx1 expression was downregulated in differentiating neurons and localised in the ciliary marginal zone (CMZ), which corresponds to the proliferating region (Chuang et al., 1999) (Fig. 2B ).
In forskolin-treated retinas, expression of rx1 was not downregulated and it remained expressed throughout the neural retina ( Fig. 2A ). Forskolin-treated retinas were labelled with the anti-phosphorylated histone H3 antibody, which can label mitotic cells in the late G2 and M phases (Wei and Allis, 1998) . In 2-dpf wild-type retinas, the nuclei of dividing cells were localised to the CMZ (Fig. 2D ). In forskolin-treated retinas, dividing cells were still detected at the ventricular surface throughout the neural retina and they did not localise to the CMZ (Fig. 2C) . We examined BrdU incorporation in forskolin-treated retinas. The ratio of BrdU-positive retinal cells was higher in forskolin-treated retinas than in control DMSO-treated retinas (Fig. 2E,F,I ). These data suggest that a large population of retinal cells is mitotic in the presence of forskolin.
To exclude the possibility that postmitotic cells die immediately after their generation in the presence of forskolin, their cell death pattern was examined by labelling with Acridine Orange. Apoptosis was observed in both forskolintreated and control DMSO-treated retinas but its spatiotemporal cell death pattern did not correlate with the pattern of progression of ath5 expression (data not shown). Even though their cell death pattern does not correlate to the pattern of progression of ath5 expression, forskolin treatment has an effect on the maintenance of retinal cells. TUNEL analysis of cryosections revealed that at 33 hpf the number of apoptotic cells in the presence of forskolin was more than three times higher than that in the presence of DMSO (Fig. 2G,H,J) , suggesting that forskolin treatment affects the survival of mitotic retinal cells. From 33 to 48 hpf, the number of apoptotic cells increased not only in forskolin-treated retinas but also in DMSO-treated retinas (Fig. 2J) , suggesting that retinal cells are sensitive to DMSO after 33 hpf.
PKA inhibits the exit of retinoblasts from Wntdependent cell-cycle progression
To elucidate whether PKA inhibits cell-cycle exit upstream of cyclin D1 and p27, we examined the expression of these genes in forskolin-treated retinas. To identify zebrafish p27 genes, we searched the zebrafish genome database and found that there are at least two p27 homologues in zebrafish, which are designated p27a and p27b (see Materials and methods). The phylogenetic relationship among the p27 family proteins In the forskolin-treated retina (C), antibody staining was observed in the CMZ (arrow) and at the ventricular surface of the neural retina (arrowheads), whereas only a few mitotic cells were observed in the CMZ (arrow) of the DMSO-treated retina (D). (E,F) BrdU labelling of 48-hpf forskolin-treated (E) and DMSO-treated (F) retinas. In the forskolin-treated retina, most of retinal cells are BrdU positive, whereas cell division seems to cease in the RGC and amacrine cell layers (asterisk) in the DMSO-treated retina. (G,H) TUNEL analysis of 33-hpf forskolin-treated (G) and DMSO-treated (H) retinas. Patterns of cell apoptosis (green) do not correlate with those of neuronal production in forskolin-treated retinas (G; data not shown), although the number of apoptotic cells is higher than in DMSOtreated retinas (H). (I) Ratios of BrdU-positive areas to total area in forskolin-and DMSO-treated retinas. Bars indicate the average ratios that were observed in cryosections of the retinas labelled with the anti-BrdU antibody. The numbers of embryos examined were n=3 and n=2 for forskolin treatment and DMSO treatment (DMSO 18-48) between 18 and 48 hpf, respectively. Four sections from the nasal to temporal regions were examined per embryo. (J) Quantification of apoptotic cells in forskolin-and DMSO-treated retinas. Bars indicate the average number of apoptotic cells observed in cryosections corresponding to the central retina subjected to TUNEL. One section was examined per embryo. The numbers of embryos examined were n=7 for forskolin treatment between 18 and 33 hpf , n=3 for DMSO treatment between 18 and 33 hpf , n=5 for forskolin between 18 and 48 hpf , and n=3 for DMSO treatment between 18 and 48 hpf . CMZ, ciliary marginal zone; fb, forebrain; FK, forskolin; ls, lens; ONL, outer nuclear layer.
revealed that p27a is similar to mouse and human p27, whereas p27b is more similar to Xenopus p27 (Fig. 3A) . In situ hybridisation analysis revealed that p27b is expressed in the zebrafish retina, whereas p27a is expressed in the lens rather than in the neural retina (data not shown). p27b expression was probably localised in mitotic retinoblasts and early differentiating neurons ( Fig. 3B ; data not shown). p27b expression was markedly weak or absent in forskolin-treated retinas (Fig. 3C ). The expression of cyclin D1 was downregulated in differentiating neurons and localised in the CMZ in wild-type retinas (Fig. 3D) . However, cyclin D1 expression was not downregulated and remained in a large area of the forskolin-treated retina (Fig. 3E ). We examined the transcription level of cyclin D1 by the quantitative PCR analysis and found that the transcription level of cyclin D1 is relatively normal in forskolin-treated heads (data not shown), suggesting that the aberrant increase in cyclin D1 expression does not occur in the forskolin-treated retina. Furthermore, ectopic introduction of Xenopus p27 inhibited cell-cycle progression in the forskolin-treated retina ( Fig. 3F ; 100%, n=15 retinal columns), although almost all p27 nonexpressing cells were BrdU-positive. These data suggest that PKA inhibits the cell-cycle exit of retinal cells upstream of the interaction between cyclin D1 and p27.
Cyclin D1 is a direct target of Wnt/ β-catenin signalling (Tetsu and McCormick, 1999) . It was reported that canonical Wnt signalling promotes cell proliferation in chick retinas (Kubo et al., 2003) . Recently, we also found that Wnt/β-catenin signalling is activated in proliferating cells in the zebrafish retina, and that the activation of canonical Wnt signalling induces hyperproliferation in the zebrafish retina (M.Y. and I.M., unpublished). To elucidate whether Wnt/β-catenin signalling is required for PKAmediated proliferation, we examined BrdU incorporation in forskolin-treated retinas with overexpressed ∆N-Tcf3, a deletion of T cell factor 3 (Tcf3) that lacks β-catenin binding and functions as a dominant suppressor of Wnt signalling (Kim et al., 2000) . Retinal cells expressing ∆N-Tcf3 did not incorporate BrdU even in the presence of forskolin ( Fig. 3G; 100%, n=92) . These data suggest that Wnt signalling is required for PKA-mediated proliferation.
Recently, we found that proliferation is enhanced in the zebrafish retina by the introduction of ∆47-β-catenin, which lacks N-terminal phosphorylation sites and functions as a constitutively active form of β-catenin (Chenn and Walsh, 2002 ) (M.Y. and I.M., unpublished) (Fig. 3H) . To elucidate whether PKA activity is required for Wnt-mediated proliferation, we examined retinal phenotypes of embryos injected with a mixture of ∆47-β-catenin and dnPKA. The introduction of dnPKA did not suppress the hyperproliferation induced by ∆47-β-catenin (Fig. 3I ), suggesting that a high level of Wnt activity can overcome the loss of PKA activity to promote proliferation. These data suggest that Wnt signalling is epistatic to PKA in the proliferation of retinal cells.
To elucidate whether Wnt signalling is activated by PKA, Development 132 (7) Research article we used TOPdGFP transgenic fish carrying GFP under the control of a β-catenin responsive promoter (Dorsky et al., 2002) . In TOPdGFP fish, GFP is expressed in the CMZ at 2 dpf (Fig. 3J) , suggesting that the activation of Wnt signalling occurs in proliferating retinal cells. Forskolin treatment did not enhance this GFP expression in the neural retina (Fig. 3K) , suggesting that PKA does not activate the Wnt signalling pathway. Together, these data suggest that PKA inhibits exit from the Wnt-mediated cell cycle, rather than stimulating cellcycle progression through the activation of Wnt signalling.
The cell-cycle exit of retinal mitotic cells is affected in the blockade of Smo and Gli functions
A previous study demonstrated that the induction and progression of ath5 expression are variably perturbed in the zebrafish smo mutant slow-muscle-omitted (smu) (Stenkamp b577-/-heads using antibodies against Ser133-phosphorylated CREB (upper) and CREB (lower). The phosphorylation of CREB is more than 70 times higher in forskolin-treated heads than in control DMSO-treated heads. However, in smu b577-/-heads, CREB phosphorylation is decreased to one-third of the normal level. (I,J) Plastic sectioning of wild-type (I) and Gli-MO-injected (J) retinas at 3 dpf. In the severe case of Gli-MO-injected embryos, retinal lamination is severely delayed. (K-L′′) In situ hybridisation of 33-hpf wild-type (K) and Gli-MO-injected (L-L′′) embryos with an ath5 RNA probe. The progression of ath5 expression is perturbed to different degrees in Gli-MO-injected retinas, from no initiation (L), to severe (L′) or mild (L′′) inhibition. In the severe case, ath5 expression is only observed in the ventronasal retina (L′, arrowhead). (M) Quantitative assessment of ath5 expression in wild-type (orange), smu mutant (light blue), Gli-MO-injected (blue) and forskolin-treated (dark blue) embryos. Embryos were classified into four groups according to the severity of the defect in ath5 expression, as shown in (L-L′′) and counted in number. Numbers of examined embryos were n=11 for wild type, n=21 for the smu mutant, n=63 for Gli-MO-injected embryos and n>100 for forskolin-treated embryos. Almost all of the forskolin-treated embryos show the 'severe' phenotype. FK, forskolin.
and Frey, 2003) . Here, we show that the cell-cycle exit of retinal progenitor cells is perturbed in smu mutants. In smu b577-/-retinas, lamination was usually delayed (Fig. 4B,B′ ). In the smu b577 mutant, the initial induction of ath5 expression occurred in the presumptive ventronasal retina, but the progression of ath5 expression was variably affected among smu b577-/-embryos from severe (n=6/21, Fig. 4D ) to mild (n=6/21, Fig. 4D′ ). The delay of ath5 expression became less severe in the smu b577 mutant in later stages, and ath5 expression occurred in a large region of the neural retina until 3 dpf (data not shown). In 2-dpf wild-type retinas, the anti-BrdU antibody strongly labelled retinal cells in the CMZ and the outer layer, but not in the RGC and inner layers, where the majority of neuronal cells were born until 2 dpf (Fig. 4E,E′) . The ratio of BrdU-positive cells relative to the total number of cells was about 30% on average in wild-type retinas, which remained constant from the nasal to temporal regions within the optic cup (Fig. 4G) . In the severe cases of smu b577 mutants, a large number of retinal cells were BrdU-positive (Figs. 4F,F′) . On average, 70% of cells were BrdU positive in severe cases, more than twice that in wild-type embryos. BrdU labelling of serial sections of the smu b577-/-retina revealed that more than 80% of cells in the temporal region were mitotic, with the highest ratio of mitotic cells being found in the nasal-temporal axis (Fig. 4G) . Since the wave of neuronal production spreads from the nasal to temporal retina, the high ratio in the temporal retina suggests that the progression of neuronal production is delayed in smu b577-/-retinas. The progression of retinal neurogenesis is more severely inhibited in embryos treated with forskolin than in the smu mutant. The difference between forskolin treatment and the genetic blockade of Smo function might be the level of PKA activity. One of the major substrates of PKA is the cAMPresponsible element binding factor (CREB) (Lonze and Ginty, 2002) . Because PKA phosphorylates Ser133 of CREB, we examined the level of this phosphorylation in forskolin-treated and smu mutant embryos. Western blot analysis with an antibody against phosphorylated Ser133 of CREB revealed that the level of CREB phosphorylation is much higher in forskolintreated embryos than in control DMSO-treated embryos (Fig.  4H ). By contrast, the level of CREB phosphorylation was not elevated in smu mutants (Fig. 4H) . These data suggest that high activation of PKA occurs only after forskolin treatment.
As PKA inhibits the Hh signalling pathway by generating the repressor form of Gli, the repressor activity of Gli may be higher in the presence of forskolin than when Smo function is blocked. If this is the case, the level of the Gli repressor activity may correlate with the severity of the defect in retinal neurogenesis. An alternative possibility is that PKA activates Hh-independent signalling pathways, such as CREB, which might contribute to the forskolin-induced phenotype. To distinguish between these possibilities, we examined retinal phenotypes caused by the inhibition of Gli proteins, which function downstream of PKA. To inhibit Gli function, embryos were injected with a mixture of morpholino antisense oligonucleotides of Gli1 and Gli2 (Gli-MO). In Gli-MOinjected embryos, retinal lamination was severely delayed, as in the smu mutant (Fig. 4I,J) . In Gli-MO-injected retinas, the progression of ath5 expression was variably perturbed from no expression (n=12/63, Fig. 4L ) to severe (n=36/63, Fig. 4L′ ), mild (n=5/63, Fig. 4L′′ ) and almost normal (n=10/63, data not shown) expression. The severity of the progression defect in Gli-MO-injected embryos is intermediate between that observed in forskolin-treated embryos and that seen in smu mutant embryos (Fig. 4M) . These data suggest that the blockade of Gli functions causes defects in the cell-cycle exit of retinal progenitor cells. Together, these data suggest that PKA inhibits Hh-mediated Gli activation, which regulates the progression of neuronal production.
A wave of ath5 expression spreads to the temporal retina earlier than that of shh:GFP expression Zebrafish Shh and Twhh are expressed in RGCs and induce RGC differentiation in neighbouring uncommitted areas (Neumann and Nuesslein-Volhard, 2000) , raising the possibility that Hh produced by RGCs promotes mitotic retinoblasts to generate neurons. If this is the case, the progression of ath5 expression must spatially and temporally correlate with that of RGC differentiation. However, several contradictory observations have been reported. Because the first RGCs start to extend their axons at 28 hpf (Laessing and Stuermer, 1996; Schmitt and Dowling, 1996) , there is at least a 3-4 hour time lag between ath5 expression and this first morphological appearance of RGC differentiation. Furthermore, cyclopamine treatment after 26 hpf completely inhibits the progression of RGC differentiation (Neumann and Neusslein-Volhard, 2000) , although the progression of ath5 expression is only mildly delayed by treatment with cyclopamine after 27 hpf (Stenkamp and Frey, 2003) . These observations suggest that the progression of ath5 expression does not strongly correlate with that of RGC differentiation. To elucidate why this lack of correlation occurs, we examined ath5 and shh expression in more detail. shh expression was monitored by GFP expression under the control of shh retinal enhancers (referred to as shh:GFP). shh:GFP was expressed in the ventral forebrain only, and was not in the eye until at least 27 hpf (data not shown). shh:GFP expression was detected in a few cells in the ventronasal retina adjacent to the optic stalk at 29 hpf (Fig. 5A ). Faint expression of shh:GFP progressed to the dorso-nasal retina at 31 hpf (Fig. 5B) . shh:GFP expression spread to the temporal retina at 35 hpf (Fig. 5C ). This expression profile is consistent with previous published data (Neumann and Nuesslein-Volhard, 2000) , and suggests that shh:GFP expression correlates with the maturation of RGCs.
To facilitate the detection of ath5 expression with high sensitivity, we used the transgenic line Tg(ath5:GFP) (Masai et al., 2003) . BrdU labelling of retinas expressing ath5:GFP showed that ath5:GFP-expressing cells were BrdU-negative, suggesting that ath5:GFP is a marker of newly-generated postmitotic cells (Fig. 5D) . Similar to the results of in situ hybridisation, ath5:GFP expression started in the ventronasal retina at 25 hpf (Fig. 5E ). Compared with in situ hybridisation, it was more clearly demonstrated that the wave front of ath5 expression had already reached the temporal retina at 27 hpf, although the density of GFP-positive cells was low (Fig. 5F ). At 31 hpf, the area where ath5:GFP-positive cells were located became slightly larger and the number of ath5:GFP-positive cells increased (Fig. 5G) . These data suggest that the wave of ath5:GFP expression progresses earlier than that of shh:GFP expression. To exclude the possibility that the time lag between ath5:GFP and shh:GFP is due to the difference of transgenic strains, we confirmed that ath5 mRNA expression spreads to the temporal retina at 29 hpf in shh:GFP transgenic embryos (Fig. 5H) .
Forskolin treatment inhibits two distinct steps for RGC differentiation
The profile of ath5:GFP expression suggests that Hh signalling present before 27 hpf regulates the progression of neuronal production. To determine the critical period when Hh signalling is required for the progression of ath5 expression, forskolin was applied within different time windows (Fig. 6M) .
To estimate the time lag from the forskolin treatment to the inhibition of Hh signalling pathway, we monitored ptc1 expression during and after the forskolin pulse treatment. The expression of ptc1 is regulated by Hh signalling and occurs in the ventral part of CNS at 24 hpf (Fig. 6A) (Concordet et al., 1996) . Two hours after the start of forskolin treatment, ptc1 expression severely decreased (n=5/5, Fig. 6B ), suggesting that Hh signalling is suppressed within 2 hours of forskolin treatment (Fig. 6E) . Two hours after the removal of forskolin, ptc1 expression remained downregulated (n=6/6, Fig. 6C ). By 4 hours after the removal of forskolin, ptc1 expression had increased but was not fully recovered (data not shown). By 6 hours after the removal of forskolin, ptc1 expression levels had recovered to the levels seen in control DMSO-treated embryos (n=6/6, Fig. 6D ). These data suggest that Hh signalling is recovered between 2 and 6 hours after the removal of forskolin (Fig. 6E) .
Here we monitored ath5:GFP and shh:GFP as markers of newly generated neurons and mature RGCs, respectively. Forskolin treatment before 22 hpf had no effect on the progression of ath5:GFP expression (Fig. 6F) . Treatment from 18 to 24 hpf induced various phenotypes of ath5:GFP expression ( Fig. 6G-G′′) , suggesting that forskolin treatment around 24 hpf inhibits the progression of ath5:GFP expression. Indeed, forskolin treatment between 22 and 26 hpf completely inhibited the progression of ath5:GFP expression (Fig. 6H) . Interestingly, forskolin treatment after 27 hpf failed to block the progression of ath5:GFP expression (Fig. 6J) but completely inhibited the progression of the expression of shh:GFP (Fig. 6K) and that of another RGC marker, islet1 (data not shown). To exclude the possibility that it is the difference in the transgenic strains that causes a different response to forskolin treatment between ath5:GFP and shh:GFP expression, we confirmed that ath5 mRNA spreads to the large region of the neural retina in the Tg(shh:GFP) embryo shown in Fig. 6K (Fig. 6L) . Together, these data suggest that Hh signalling regulates two distinct steps of RGC differentiation: cell-cycle exit of retinoblasts and the progression of ath5-positive immature neurons to mature RGCs. Considering the time lag between forskolin treatment and inhibition of the Hh signalling pathway (Fig. 6N) , Hh signalling must regulate the progression of ath5 expression between 24 and 29 hpf. Hh signalling after 29 hpf is not essential for the progression of ath5 expression but is still required for the progression of RGC maturation.
Morpholino-antisense oligonucleotides for shh and twhh inhibits the wave of neuronal production
Pulse treatment with forskolin suggests that the wave of ath5 expression is regulated by Hh activity that is present before 29 hpf. shh:GFP expression is initiated at 29 hpf (Fig. 5A) . It was reported that shh RNA starts to be expressed at 28 hpf (Neumann and Nuesslein-Volhard, 2000) . These observations raise the possibility that there is a very weak expression of shh and twhh in 24-to 29-hpf retinas, which is sufficient to regulate the wave of ath5 expression. Alternatively, it is possible that Hh proteins other than Shh and Twhh regulate the progression of ath5 expression. A third possibility is that ath5 expression is not regulated by the short-range action of Hh signalling within the neural retina, but by the long-range action of Hh expressed in other tissues. To investigate whether inhibition of the Shh-and Twhhmediated pathway has an effect on the progression of ath5 expression, we examined the phenotypes of embryos injected with a mixture of morpholino-antisense oligonucleotides for Shh and Twhh (hh-MO). In hh-MO-injected retinas, the progression of ath5 and islet1 expression was perturbed (Fig.  7B,D) . Retinal cells in hh-MO-injected embryos largely incorporated BrdU (Fig. 7F) . The severity of the defect in ath5 expression in hh-MO-injected embryos was similar to that in Gli-MO-injected embryos (Fig. 7G, compare with Fig. 4M ), suggesting that Shh and Twhh regulates the progression of ath5 expression. To elucidate whether the local depletion of Shh and Twhh activities within the neural retina affects ath5 expression, hh-MO-injected donor cells were transplanted into wild-type host retinas. In this experiment, to facilitate the detection of ath5 expression, we used the transgenic line Tg(ath5:GFP). ath5:GFP expression was rarely observed in retinal cells derived from hh-MO-injected donor cells (Fig. 7H,I ; n=5/5 embryos), and in some cases, ath5:GFP was not detected in wild-type cells located adjacent to the temporal side of hh-MOinjected cells (Fig. 7J) , suggesting that Hh activity in the neural retina is necessary to regulate the progression of ath5 Development 132 (7) Research article expression. Taken together, these data suggest that short-range Shh and Twhh signalling regulates the wave of neuronal production in the zebrafish retina.
Discussion
In this paper, we show that the progression of neuronal production in the zebrafish retina is completely inhibited by the activation of PKA, which negatively regulates Hh signalling. The blockade of Hh signalling molecules, including Hh, Smo and Gli, induces similar defects in the wave of neuronal production. These data suggest that Hh signalling regulates the progression of neuronal production in the zebrafish retina. In the presence of forskolin, one or two postmitotic neurons are generated adjacent to the optic stalk. This observation indicates that the initial induction of retinal neurogenesis is independent of PKA and is tightly localised in one or two cells located adjacent to the optic stalk, supporting the idea that signals from the optic stalk regulate the initial induction of neuronal production (Masai et al., 2000) . A previous study reported that Shh is expressed in mature RGCs and acts on neighbouring undifferentiated cells to induce RGC differentiation (Neumann and Nuesslein-Volhard, 2000) , raising the possibility that Shh expressed in RGCs induces neighbouring mitotic progenitor cells to exit from the cell cycle. However, we show that Hh signalling regulates two distinct steps of RGC differentiation: the cell-cycle exit of retinoblasts and RGC maturation. This dual requirement of Hh signalling in RGC differentiation suggests that the mechanism underlying the neurogenic wave in the zebrafish retina is more complex than that in the Drosophila compound eye.
PKA inhibits cell-cycle exit of retinoblasts through interaction with both Hh and Wnt signalling
In the presence of forskolin, cyclin D1 expression is not downregulated and p27 expression severely decreases. Furthermore, the introduction of p27 inhibits cell-cycle progression even in the presence of forskolin. These data suggest that PKA promotes cell proliferation upstream of the interaction between cyclin D1 and p27. It was reported that cyclin D1 is a direct target of Wnt/β-catenin signalling (Tetsu and McCormick, 1999; Shtutman et al., 1999) . We found that ∆47-β-catenin promotes the proliferation of retinal cells in zebrafish, and that ∆N-Tcf3 inhibits the proliferation of retinal cells induced by forskolin treatment. These data suggest that Wnt/β-catenin signalling is required for PKA-mediated proliferation. However, dnPKA does not suppress Wnt-induced overproliferation, suggesting that a high level of Wnt activity maintains cell proliferation in the absence of PKA activity. Together, these data suggest that PKA plays a supplemental role in Wnt-induced proliferation, or that PKA inhibits exit from Wnt-mediated cell-cycle progression rather than promoting cell-cycle progression in concert with Wnt signalling.
What is the molecular mechanism that underlies PKAmediated inhibition of retinal neurogenesis? There are two possible pathways (Fig. 8A) . One possibility is that PKA inhibits the expression of the cdk inhibitor p27. Because PKA antagonises the Hh signalling pathway, Hh-mediated Gli activation may be required for p27 expression in the zebrafish retina. Although it is unknown whether Gli transcription factors directly regulate the transcription of p27, the activator form of Gli may positively regulate the expressison of p27. It was reported that Indian Hh induces colonic epithelial differentiation by antagonising Wnt/β-catenin signalling (van den Brink et al., 2004) . In this case, Hh signalling is required for activation of the cdk inhibitor Cip1/Waf1/p21, and negatively regulates cyclin D1, suggesting that a common mechanism may regulate both zebrafish retinal neurogenesis and mouse colonic epithelial differentiation. Although Gli-MO injection induces severe defects in the progression of neuronal production, it is also possible that PKA promotes cell proliferation though Gli-independent pathway. One of the major PKA substrates, CREB, binds to the promoter of cellcycle regulators such as cyclin D1 (Lonze and Ginty, 2002) . PKA phosphorylates Ser133 of CREB and this phosphorylated form of CREB recruits p300/CBP histone acetyltransferase (HAT) to activate the transcription of cyclin D1. As ∆N-Tcf3 inhibits cell-cycle progression in the presence of forskolin, phophorylated CREB may activate the transcriptional activity of Tcf3/β-catenin complex in this model. We show that forskolin treatment does not activate transcription under the control of the β-catenin responsive promoter (Fig. 3K) . However, this is not contradictory to this model, because the β-catenin responsive promoter does not contain the CREBbinding sequence. In the developing mouse cerebellum, Shh induces G1-S transition to promote proliferation of granule cell precursors (Wechsler-Reya and Scott, 1999) , whereas an extracellular matrix protein, Vitronectin, promotes granule cell differentiation through PKA-mediated CREB phosphorylation (Pons et al., 2001) . As Shh suppresses PKA-mediated CREB phosphorylation in cerebellar development, competition between the Shh and PKA-CREB pathway determines whether granule cell precursors continue to proliferate or whether they differentiate. Although the role of Hh in cerebellar development is the reverse of that in zebrafish retinal development, the PKA-CREB pathway may be involved in the switch between proliferation and differentiation in the zebrafish retina.
Forskolin treatment inhibits retinal neurogenesis more severely than cyclopamine treatment or the smu mutation The progression of neuronal production is completely inhibited in the presence of forskolin, but is only delayed in the smu mutant and following cyclopamine treatment. Milder defects in ath5 expression in smu mutant retinas may be due to maternal Smu activity. However, the delay of neurogenesis in the presence of cyclopamine is difficult to explain by such redundancy. One possibility is that cyclopamine treatment is insufficient to block Hh signalling completely. Recently, it was Development 132 (7) Research article reported that cyclopamine has a relatively low affinity for Smo (Williams et al., 2003; Romer et al., 2004) . Furthermore, cyclopamine is hydrophobic chemical. These characteristics may result in an incomplete inhibition of Hh signalling. An alternative possibility is that the blockade of Smo function is not sufficient to inhibit the progression of neuronal production in the zebrafish retina. Western blotting with an antibody against phosphorylated CREB suggests that the level of PKA activity is much higher in forskolin-treated embryos than in wild-type and smu mutant embryos. The level of PKA activity may correlate with the severity of defects in ath5 expression. Although it still remains to be elucidated how PKA inhibits the Hh signalling pathway in vertebrates, it is generally accepted that PKA negatively regulates Hh-dependent Gli activation by promoting the cytoplasmic sequestration of Gli1 and generating the repressor forms of Gli2 and Gli3 (Ingham and McMahon, 2001) . It is possible that the ratio of the repressor form to the activator form of Gli proteins is higher following forskolin treatment than it is following cyclopamine treatment or in smu mutants. High predominance of repressor activity over activator activity may be necessary to inhibit progression of neuronal production. This idea seems to be supported by our observation that progression of neuronal production is more severely affected in Gli-MO-injected retinas than in smu mutant retinas (Fig. 4M) . Another possibility is that the activation of CREB contributes to the forskolin-induced defects in neuronal production. Because phosphorylation of CREB by PKA activates the transcription of cyclin D1 (Lonze and Ginty, 2002) , CREB-mediated activation of cyclin D1 expression may inhibit the cell-cycle exit of retinoblasts in concert with the blockade of Hh-mediated Gli activation.
Hh signalling regulates two distinct steps of RGC differentiation A previous study suggested that shh is expressed in RGCs and induces neighbouring uncommitted cells to differentiate into RGCs (Neumann and Nuesslein-Volhard, 2000) . In this study, we show that Hh signalling promotes mitotic retinoblasts to generate postmitotic daughter cells. These results raise the possibility that Hh signals emanating from RGCs induce adjacent mitotic cells to generate neurons that become RGCs and function as a new source of Hh signals. However, the wave front of ath5 expression reaches the temporal retina at 27 hpf, before the first differentiated RGC starts axonogenesis (Laessing and Stuermer, 1996) , which suggests that mature RGCs are not the source of Hh signals. Furthermore, this early spread of ath5 expression seems contradictory to the previous observation that blockade of Hh signalling by cyclopamine after 26 hpf strongly inhibits the progression of RGC differentiation (Neumann and Nuesslein-Volhard, 2000) . These data suggest that the wave of ath5 expression does not strongly correlate with that of RGC differentiation. In this study, we show that forskolin treatment after 27 hpf has no effect on the progression of ath5 expression, but that it does inhibit the progression of markers of mature RGCs. These data suggest that Hh signalling regulates two distinct steps of RGC differentiation: the cell-cycle exit of retinoblasts and the progression of ath5-positive neurons into mature RGCs. Considering the time lag between forskolin treatment and the inhibition of Hh signalling, Hh signalling after 29 hpf does not regulate the progression of ath5 expression but does regulate the progression of RGC differentiation (Fig. 6N) . After 29 hpf, Hh may promote the progression of uncommitted postmitotic neurons into mature RGCs. This later requirement of the Hh signalling pathway for RGC differentiation is consistent with the previous observation of Neumann and Nuesslein-Volhard (Neumann and Nuesslein-Volhard, 2000) .
In this study, we show that only forskolin treatment completely inhibits the progression of neuronal production; the progression of neuronal production is only delayed following cyclopamine treatment or in the smu mutation (Stenkamp and Frey, 2003) . However, it was reported that the progression of RGC maturation is severely inhibited by treatment with cyclopamine (Neumann and Nuesslein-Volhard, 2000) . These observations suggest that mild blockade of Hh signalling is sufficient to inhibit the progression of RGC maturation, whereas severe blockade of Hh signalling is necessary to inhibit the progression of neuronal production. If this is the case, it is possible that a low dose of Hh signals is sufficient to induce the cell-cycle exit of retinoblasts, while a high dose of Hh signals is necessary to promote the progression of ath5-positive cells into mature RGCs. This idea seems to be consistent with a model proposing that early differentiating cells near the wave front of neuronal production express a low level of Hh, which acts on adjacent retinoblasts causing them to exit from the cell cycle, and that mature RGCs express a high level of Hh, which acts on adjacent uncommitted neurons causing them to differentiate into mature RGCs (Fig. 8B) .
What is the significance of such dual regulation of Hh signalling in RGC differentiation? Initial Hh signalling generates ath5-positive neurons, which might be uncommitted to any retinal cell-types. Later Hh signalling promotes ath5-positive neurons to differentiate into RGCs. It is possible that some ath5-positive neurons do not respond to the later Hh signals and differentiate into other types of retinal cells, such as amacrine cells. If this is the case, the dual actions of Hh play a role in the generation of diversity of retinal cell-types through the maintenance of a pool of uncommitted neurons. As another possibility, a pool of uncommitted neurons may be useful to regulate the number of RGCs during development. The most recent study revealed that Shh is expressed in amacrine cells and directs the differentiation and lamination of the inner and outer nuclear layers (Shkumatava et al., 2004) . Although the authors showed that Shh expression in amacrine cells is independent of RGC differentiation, it is unknown whether Shh expression in amacrine cells requires the initial action of Hh signals that mediate cell-cycle exit of retinoblasts. In the future, it will be important to elucidate whether shh-expressing amacrine cells are generated from a pool of ath5-positive neurons.
Short-range action of Shh and Twhh regulates the progression of ath5 expression in zebrafish
Pulse treatment results suggest that Hh signalling between 24 and 29 hpf is required for the wave of ath5 expression (Fig. 6N) . Furthermore, the introduction of shh and twhh morpholino-antisense oligonucleotides blocks neuronal production in the retina. These data suggest that Shh and Twhh regulate the progression of ath5 expression between 24 and 29 hpf. However, it is difficult to detect shh and twhh mRNA expression in the neural retina at this early stage, although it was reported that shh RNA is expressed in the retina at 28 hpf (Neumann and Nuesslein-Volhard, 2000) . One possibility is that Shh and Twhh expressed in the ventral forebrain may have a long-range action on progenitor cells of the optic cup. It was reported that Hh expressed in midline tissue is important for proliferation of the developing forebrain in chicks and mice, probably through its long-range actions (Britto et al., 2002; Ishibashi and McMahon, 2002) . The most recent study on Hh signalling in the zebrafish retina also suggested that Hh signalling outside the optic cup regulates ath5 expression before 27 hpf (Stenkamp and Frey, 2003) . However, we do not consider this as the most likely explanation, as the wave of ath5 expression normally occurs when the optic cups are dissected from the forebrain at 18 hpf, and cultured as an explant later (Masai et al., 2000) , suggesting that a source of Hh signals is localised within the optic cup. Furthermore, when the dissected eye cup was divided into two (the nasal and temporal halves) only the nasal half expressed ath5 (Masai et al., 2000) , suggesting that short-range Hh signalling acts from the nasal to temporal regions across the neural retina. Transplantation of hh-MO-injected cells into wild-type host retinas demonstrated that ath5 expression is rarely observed in hh-MO-injected retinal columns, and that wild-type cells fail to express ath5 when they are located adjacent to the temporal side of Shh-and Twhh-deprived cells. These data suggest that a short-range action of Shh and Twhh expressed in the neural retina regulates the wave of ath5 expression and neuronal production. Low levels of Shh and Twhh expression may spread to the temporal retina up until 27 hpf and may be sufficient to regulate the wave of ath5 expression.
Does Hh function as a mitogen or an anti-mitogen in the vertebrate retina?
In this study, we propose that Hh signals induce the cell-cycle exit of retinal progenitor cells. However, several studies have suggested that Hh functions as a mitogen for neural stem cells in the retina and in the brain, for astrocyte precursor cells in the optic stalk, and for granule cell precursors in the cerebellum (Roy and Ingham, 2002; Ruiz i Altaba et al., 2002) . The observation of such an opposite phenotype may be due to the difference in cell types or the species used in the studies. Otherwise, as discussed previously (Yang, 2004) , the difference in the dose of Hh signals may cause the opposite behaviour of retinal progenitor cells. For example, a low dose of Hh signals as an anti-mitogen promotes neuronal production, whereas a high dose of Hh signals inhibits the differentiation of early-born cell types to maintain a pool of mitotic cells for the generation of late-born cell types. In Drosophila eyes, Hh regulates not only neuronal differentiation by inducing the proneural gene atonal, but also proliferation by inducing cyclin D/E (Duman-Scheel et al., 2002) . Such dual roles of Hh as a mitogen and an anti-mitogen may coordinate proliferation with cell differentiation in the vertebrate retina.
The mitogenic role of Hh has been proposed from in vitro experiments carried out using cell pellets or explant culture. Recent in vivo analyses of the role of Hh in the vertebrate retina showed different phenotypes of retinal neurogenesis. In conditional shh knock-out mice, Müller glial cells fail to differentiate properly and the outer photoreceptor layer shows a rosette structure . In frog retina treated with the Hh inhibitor cyclopamine, retinal progenitor cells are normal and only differentiation of the pigmented epithelium is perturbed (Perron et al., 2003) . We could not detect any defects in the differentiation of the pigment epithelium in zebrafish embryos treated with forskolin or in smu -/-embryos. The roles of Hh signalling in retinal development may be diverse among different species of vertebrates. In the future, it will be important to elucidate why retinal cells show such different behaviours in response to Hh signals.
